Related Experiment Video
Updated: Aug 13, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
Familial combined hyperlipidemia in a North Indian kindred
C S Sriram1, Sheffali Gulati, Vikas Chopra
1Department of Pediatrics, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India.
Insights
Familial combined hyperlipidemia, a common genetic disorder, was observed in a North Indian family across three generations. Dietary therapy failed in a young infant, prompting exploration of new treatment options for this condition.
Area of Science:
- Genetics
- Cardiovascular Medicine
- Metabolic Disorders
Background:
- Familial combined hyperlipidemia (FCH) is the most prevalent genetic hyperlipidemia, strongly linked to premature coronary artery disease.
- Genetic heterogeneity and lack of a definitive diagnostic marker complicate FCH diagnosis.
- Understanding the genetic basis and clinical manifestations of FCH is crucial for early intervention.
Observation:
- A North Indian kindred spanning three generations presented with a pattern suggestive of autosomal dominant inheritance of combined dyslipidemia.
- The proband, a 4-month-old male, was incidentally found to have lipaemic serum, leading to further evaluation.
- Lipaemia retinalis was observed in the infant, while xanthomas and coronary artery disease were absent in the kindred.
Findings:
- All affected individuals exhibited combined dyslipidemia, characterized by elevated total cholesterol (predominantly LDL) and triglycerides.
- The proband and his maternal grandmother displayed an atherogenic lipoprotein phenotype.
- Dietary therapy proved ineffective in the proband, highlighting potential challenges in management.
Implications:
- This case report underscores the complex genetic nature of familial combined hyperlipidemia.
- The failure of dietary therapy in the proband suggests the need for alternative or advanced therapeutic strategies.
- Further research into novel treatment options is warranted for effective management of FCH and prevention of cardiovascular complications.
Abstract:
Familial combined hyperlipidemia is the most common genetic hyperlipidemia and is responsible for premature coronary artery disease. It is genetically heterogenous and no single diagnostic marker exists. The authors report an affected North Indian kindred spanning three successive generations with a possible autosomal dominant pattern of inheritance and all of them had combined dyslipidemia [elevated total cholesterol, predominantly the low density lipoprotein (LDL) fraction and elevated triglycerides]. The proband, a 4-month-old male baby, was incidentally discovered to have a lipaemic serum and so further evaluated. Both the index case and his maternal grandmother, a non-obese diabetic (type 2) with hypertension, had an atherogenic lipoprotein phenotype. Lipaemia retinalis was documented in this baby but xanthomas and coronary artery disease were not noted in the kindred. The present case report highlights the failure of dietary therapy in the proband and explores new options.
Related Concept Videos
Lipid Digestion
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Type II Diabetes I: Introduction
Lipids: Dietary Sources and Requirements
Cholesterol: Significance and Regulation
Considering cholesterol and...